LOS ANGELES, Feb. 11, 2014 /PRNewswire/ — Zynx Health, the market leader in providing evidence- and experience-based clinical improvement solutions, today announced the upcoming release of a new—and revolutionary—family of products called ZynxAnalytics. The first release in this innovative product line, Knowledge Analyzer™, is a scalable solution that enables healthcare organizations to analyze vast amounts of clinical content against the most current evidence—within minutes—bringing added transparency to clinical practice.
Hospitals and health systems have typically struggled with optimizing their electronic content with the most current evidence. A Knowledge Analyzer assessment will instantly pinpoint opportunities essential to decreasing care variation and improving performance in clinician practices, focusing on the most vital interventions that advance clinical and financial outcomes.
“With Zynx Health as our partner for the past five years, we have successfully integrated robust clinical decision support into our hospital’s care processes. The result is an electronic system that hard-wires evidence into patient care and makes it easy for clinicians to do the right thing, leading to tangible outcomes such as significant reductions in inpatient mortality,” said Jeremy Theal, chief medical information officer, North York General Hospital in Toronto, Canada. “We are pleased to be a partner in the development of this cutting-edge technology. With Knowledge Analyzer, we are able to gain further transparency into clinical practices, allowing us to fine-tune our patient care processes and meet evolving healthcare mandates.”
In the current era of healthcare reform, hospitals and health systems face numerous incentives and requirements to provide high-quality care across the continuum. Knowledge Analyzer enables healthcare organizations to drive compliance for performance and quality measures related to some of the most demanding mandates including: Meaningful Use Stage 2 requirements; Centers for Medicare & Medicaid Services (CMS) Accountable Care Organizations; and Value-Based Purchasing, among many others.
“Zynx Health is committed to innovative solutions that provide care guidance at the most vital moments of an individual’s health journey,” said Bertina Yen, MD, MPH, executive vice president at Zynx Health. “ZynxAnalytics is a critical step toward closing the gaps in healthcare.”
A preview of Zynx Health’s newest innovations will be available at HIMSS14 in Orlando, Fla., beginning February 23, 2014.
About Zynx Health
Zynx Health, part of the Hearst Health network, is the pioneer and market leader in evidence- and experience-based clinical improvement solutions that provide the care guidance to enhance quality and decrease variation across an individual’s health journey.
Thousands of hospital organizations and providers “dare to be better” with Zynx Health’s innovative solutions based on rigorous and tested methodologies that improve performance in clinical practice. With Zynx Health, healthcare organizations exceed industry demands for delivering high-quality care at lower costs under value-based reimbursement models.
Zynx Health partners with healthcare organizations to continuously and measurably improve care every day, for every patient, every time. To learn more, visit www.zynxhealth.com or call 855.367.ZYNX.
About Hearst Health
Zynx Health is part of the Hearst Health network, which also includes FDB (First Databank), MCG (formerly Milliman Care Guidelines), and Homecare Homebase. The mission of the Hearst Health network is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person’s health journey. Each year in the U.S., care guidance from the Hearst Health network reaches 76% of discharged patients, 133 million insured individuals, 20 million home health visits, 1.88 billion retail pharmacy prescriptions, and 3.26 billion prescription claims. Extensions of the Hearst Health network include Hearst Health Ventures and the Hearst Health Innovation Lab.